Trial Profile
A retrospective trial of Fingolimod versus Natalizumab for treating multiple sclerosis: US claims database analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 21 Sep 2015 New trial record